Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance
Maicol Mancini(Université de Montpellier), Antonio Maraver(Inserm)
Cited by 10
Related Papers
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma
|Journal of Clinical Investigation|2019|51
NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinum
|EMBO Molecular Medicine|2026|0